SPDR S&P Pharmaceuticals ETF Rating → Truth about Trump you’ve never heard (From Porter & Company) (Ad) Free XPH Stock Alerts $40.39 -0.81 (-1.97%) (As of 05:32 PM ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy2.65Holdings in XPH have an aggregate rating of Moderate Buy based on 298 analyst ratings issued in the past year covering 40 companies (98.7% of the portfolio).XPH Aggregate Price Target$66.2464.25% UpsideHigh Prediction$85.44Average Prediction$66.24Low Prediction$47.27Holdings in XPH have an aggregate price target of $66.24 and a range of $47.27 to $85.44 covering 40 companies (98.7% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy17 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 40 XPH Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.51%OGNOrganon & Co.$21.35-2.8%4 of 5 stars2.50$22.60 5.9%4Positive News5.02%PFEPfizer$28.69-3.1%5 of 5 stars2.40$35.86 25.0%15Analyst Revision5.01%MRKMerck & Co., Inc.$131.090.0%5 of 5 stars2.58$131.33 0.2%12Positive News4.94%AXSMAxsome Therapeutics$74.18-3.4%5 of 5 stars2.92$121.92 64.4%13Options Volume4.88%ELANElanco Animal Health$16.49-2.6%4 of 5 stars2.57$18.29 10.9%74.78%LLYEli Lilly and Company$808.45+0.7%5 of 5 stars2.84$769.53 -4.8%19Analyst Revision4.66%ITCIIntra-Cellular Therapies$66.37-1.4%5 of 5 stars2.90$90.17 35.9%10Positive NewsGap Up4.63%PRGOPerrigo$28.12-4.1%5 of 5 stars3.00$40.67 44.6%34.62%CTLTCatalent$54.65-0.6%4 of 5 stars2.17$53.14 -2.8%12Analyst ForecastPositive News4.57%JNJJohnson & Johnson$149.70-2.5%5 of 5 stars2.46$175.86 17.5%13Ex-DividendAnalyst Forecast4.50%ZTSZoetis$170.90-0.7%5 of 5 stars3.00$211.75 23.9%74.44%JAZZJazz Pharmaceuticals$103.94-1.5%5 of 5 stars2.85$192.75 85.4%13Positive News4.34%RPRXRoyalty Pharma$26.85-1.8%5 of 5 stars3.00$46.75 74.1%4News Coverage4.25%VTRSViatris$10.53-3.2%1 of 5 stars1.33$11.00 4.5%33.99%CORTCorcept Therapeutics$27.84-2.7%5 of 5 stars3.00$40.10 44.0%4Analyst RevisionPositive News3.87%BMYBristol-Myers Squibb$41.54-1.9%5 of 5 stars2.11$60.00 44.4%192.42%ARVNArvinas$35.23-2.0%3 of 5 stars2.88$61.13 73.5%162.16%AMPHAmphastar Pharmaceuticals$43.35-0.3%5 of 5 stars2.50$66.00 52.2%4Analyst ForecastNews Coverage2.00%SAVACassava Sciences$21.80-1.4%3 of 5 stars3.00$131.00 500.9%1Gap Up1.96%TARSTarsus Pharmaceuticals$36.16+1.1%3 of 5 stars2.88$50.38 39.3%81.44%PCRXPacira BioSciences$30.32-1.3%5 of 5 stars3.00$47.40 56.3%10Positive News1.41%EYPTEyePoint Pharmaceuticals$11.11-3.1%2 of 5 stars3.00$33.71 203.5%7Gap Up1.30%PBHPrestige Consumer Healthcare$63.83-1.4%5 of 5 stars2.50$91.25 43.0%4Analyst Downgrade1.22%LBPHLongboard Pharmaceuticals$18.94-4.0%2 of 5 stars3.00$43.67 130.6%6Gap Up1.13%HRMYHarmony Biosciences$29.35-2.8%4 of 5 stars2.50$40.63 38.4%8Positive News1.02%COLLCollegium Pharmaceutical$33.82-1.1%3 of 5 stars2.20$39.00 15.3%50.97%LQDALiquidia$12.84-2.2%2 of 5 stars2.60$21.00 63.6%50.95%AMRXAmneal Pharmaceuticals$6.44-3.2%3 of 5 stars3.00$8.25 28.1%4Positive News0.94%LGNDLigand Pharmaceuticals$84.91-2.7%5 of 5 stars3.00$116.33 37.0%30.91%AMLXAmylyx Pharmaceuticals$1.78-2.7%3 of 5 stars2.25$28.67 1,510.5%80.85%SUPNSupernus Pharmaceuticals$27.77-0.4%4 of 5 stars3.00$41.00 47.6%10.73%PLRXPliant Therapeutics$13.40-5.5%4 of 5 stars3.00$45.38 238.6%9Gap Up0.60%ANIPANI Pharmaceuticals$60.36-2.1%5 of 5 stars3.00$81.00 34.2%4Insider Selling0.53%EOLSEvolus$12.45-3.8%4 of 5 stars3.00$20.60 65.5%3Analyst Forecast0.51%RVNCRevance Therapeutics$2.67-8.6%4 of 5 stars2.50$11.50 330.7%80.45%OCULOcular Therapeutix$5.80-3.3%3 of 5 stars2.83$15.17 161.5%6Gap Up0.40%XERSXeris Biopharma$1.95-3.0%3 of 5 stars3.00$4.63 137.2%40.39%TBPHTheravance Biopharma$8.55-4.8%2 of 5 stars3.00$20.50 139.8%2Analyst Upgrade0.29%FULCFulcrum Therapeutics$7.42-3.8%3 of 5 stars3.00$15.57 109.9%7Analyst ForecastOptions VolumeAnalyst Revision0.06%MRNSMarinus Pharmaceuticals$1.30+0.8%4 of 5 stars2.57$13.79 960.4%7 This page (NYSEARCA:XPH) was last updated on 5/23/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWrite this ticker symbol down…StocksToTrade**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis could mean the end of the U.S dollar…Colonial MetalsThis military-backed stock “owns” AI marketPorter & CompanyBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.